These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34961524)

  • 21. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells.
    Wang K; Chen W; Zhang Z; Deng Y; Lian JQ; Du P; Wei D; Zhang Y; Sun XX; Gong L; Yang X; He L; Zhang L; Yang Z; Geng JJ; Chen R; Zhang H; Wang B; Zhu YM; Nan G; Jiang JL; Li L; Wu J; Lin P; Huang W; Xie L; Zheng ZH; Zhang K; Miao JL; Cui HY; Huang M; Zhang J; Fu L; Yang XM; Zhao Z; Sun S; Gu H; Wang Z; Wang CF; Lu Y; Liu YY; Wang QY; Bian H; Zhu P; Chen ZN
    Signal Transduct Target Ther; 2020 Dec; 5(1):283. PubMed ID: 33277466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of cell-based pseudovirus entry assay to identify potential viral entry inhibitors and neutralizing antibodies against SARS-CoV-2.
    Hu J; Gao Q; He C; Huang A; Tang N; Wang K
    Genes Dis; 2020 Dec; 7(4):551-557. PubMed ID: 32837985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of the spike glycoprotein of human Middle East respiratory syndrome coronavirus (MERS-CoV) in virus entry and syncytia formation.
    Qian Z; Dominguez SR; Holmes KV
    PLoS One; 2013; 8(10):e76469. PubMed ID: 24098509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
    Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives.
    Tandon R; Sharp JS; Zhang F; Pomin VH; Ashpole NM; Mitra D; McCandless MG; Jin W; Liu H; Sharma P; Linhardt RJ
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33173010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An optimized and robust SARS-CoV-2 pseudovirus system for viral entry research.
    Yang P; Yang Y; Wu Y; Huang C; Ding Y; Wang X; Wang S
    J Virol Methods; 2021 Sep; 295():114221. PubMed ID: 34182038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2.
    Zhao X; Zheng S; Chen D; Zheng M; Li X; Li G; Lin H; Chang J; Zeng H; Guo JT
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of chlorine-dioxide-based oral rinses in preventing SARS-CoV-2 cell entry.
    Travis BJ; Elste J; Gao F; Joo BY; Cuevas-Nunez M; Kohlmeir E; Tiwari V; Mitchell JC
    Oral Dis; 2022 Nov; 28 Suppl 2():2481-2491. PubMed ID: 35841377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Geraniin Inhibits the Entry of SARS-CoV-2 by Blocking the Interaction between Spike Protein RBD and Human ACE2 Receptor.
    Kim YS; Chung HS; Noh SG; Lee B; Chung HY; Choi JG
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ZDHHC5-mediated S-palmitoylation of FAK promotes its membrane localization and epithelial-mesenchymal transition in glioma.
    Wang Y; Shen N; Yang Y; Xia Y; Zhang W; Lu Y; Wang Z; Yang Z; Wang Z
    Cell Commun Signal; 2024 Jan; 22(1):46. PubMed ID: 38233791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted degradation of zDHHC-PATs decreases substrate S-palmitoylation.
    Bai M; Gallen E; Memarzadeh S; Howie J; Gao X; Kuo CS; Brown E; Swingler S; Wilson SJ; Shattock MJ; France DJ; Fuller W
    PLoS One; 2024; 19(3):e0299665. PubMed ID: 38512906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-Virus Fusion Measurements Reveal Multiple Mechanistically Equivalent Pathways for SARS-CoV-2 Entry.
    Sengar A; Cervantes M; Bondalapati ST; Hess T; Kasson PM
    J Virol; 2023 May; 97(5):e0199222. PubMed ID: 37133381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Somatostatin receptor 5 is palmitoylated by the interacting ZDHHC5 palmitoyltransferase.
    Kokkola T; Kruse C; Roy-Pogodzik EM; Pekkinen J; Bauch C; Hönck HH; Hennemann H; Kreienkamp HJ
    FEBS Lett; 2011 Sep; 585(17):2665-70. PubMed ID: 21820437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
    Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB
    Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr Virus Lytic Replication Induces ACE2 Expression and Enhances SARS-CoV-2 Pseudotyped Virus Entry in Epithelial Cells.
    Verma D; Church TM; Swaminathan S
    J Virol; 2021 Jun; 95(13):e0019221. PubMed ID: 33853968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target.
    Al-Zaidan L; Mestiri S; Raza A; Merhi M; Inchakalody VP; Fernandes Q; Taib N; Uddin S; Dermime S
    Tumour Biol; 2021; 43(1):177-196. PubMed ID: 34420993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The palmitoyl acyltransferases ZDHHC5 and ZDHHC8 are uniquely present in DRG axons and control retrograde signaling via the Gp130/JAK/STAT3 pathway.
    Collura KM; Niu J; Sanders SS; Montersino A; Holland SM; Thomas GM
    J Biol Chem; 2020 Nov; 295(46):15427-15437. PubMed ID: 32958558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of protein palmitoylation in cultured hippocampal neurons by immunoprecipitation and acyl-biotin exchange (ABE).
    Brigidi GS; Bamji SX
    J Vis Exp; 2013 Feb; (72):. PubMed ID: 23438969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new intracellular targeting motif in the cytoplasmic tail of the spike protein may act as a target to inhibit SARS-CoV-2 assembly.
    Hu L; Tang Y; Mei L; Liang M; Huang J; Wang X; Wu L; Jiang J; Li L; Long F; Xiao J; Tan L; Lu S; Peng T
    Antiviral Res; 2023 Jan; 209():105509. PubMed ID: 36572190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.
    Zhu Y; Yu D; Yan H; Chong H; He Y
    J Virol; 2020 Jul; 94(14):. PubMed ID: 32376627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.